Literature DB >> 6130402

Deficient sulphoxidation status and D-penicillamine toxicity.

G S Panayi, G Huston, R R Shah, S C Mitchell, J R Idle, R L Smith, R H Waring.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6130402     DOI: 10.1016/s0140-6736(83)91526-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  Immunotoxicology: suppressive and stimulatory effects of drugs and environmental chemicals on the immune system. A discussion.

Authors:  E Gleichmann; I Kimber; I F Purchase
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

Review 2.  Drug toxicity.

Authors:  H A Bird
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

3.  Penicillamine induced myasthenia reactivated by gold.

Authors:  A P Moore; A C Williams; P Hillenbrand
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-21

4.  Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.

Authors:  S C Mitchell; R H Waring; C S Haley; J R Idle; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

5.  Adverse effects of drugs on the blood.

Authors:  J S Meulenhoff
Journal:  Pharm Weekbl Sci       Date:  1984-02-24

6.  Reduced sulphoxidation capacity in D-penicillamine induced myasthenia gravis.

Authors:  P Seideman; R Ayesh
Journal:  Clin Rheumatol       Date:  1994-09       Impact factor: 2.980

Review 7.  Genetically determined variability in acetylation and oxidation. Therapeutic implications.

Authors:  D W Clark
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

Review 8.  Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine.

Authors:  George J Kontoghiorghes; Katia Neocleous; Annita Kolnagou
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

9.  Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease.

Authors:  C Astbury; A J Taggart; L Juby; L Zebouni; H A Bird
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.